Predictmedix Financial Statements From 2010 to 2026

PMEDF Stock  USD 0.05  0.00  0.00%   
Predictmedix's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Predictmedix's valuation are provided below:
Predictmedix does not presently have any trending fundamental ratios for analysis.
Check Predictmedix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Predictmedix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Predictmedix financial statements analysis is a perfect complement when working with Predictmedix Valuation or Volatility modules.
  
This module can also supplement various Predictmedix Technical models . Check out the analysis of Predictmedix Correlation against competitors.

Predictmedix Company Return On Equity Analysis

Predictmedix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Predictmedix Return On Equity

    
  -2.0  
Most of Predictmedix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Predictmedix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Predictmedix has a Return On Equity of -1.9957. This is 91.67% lower than that of the Healthcare sector and 77.14% lower than that of the Medical Devices industry. The return on equity for all United States stocks is notably higher than that of the company.

Predictmedix Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Predictmedix's current stock value. Our valuation model uses many indicators to compare Predictmedix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Predictmedix competition to find correlations between indicators driving Predictmedix's intrinsic value. More Info.
Predictmedix is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Predictmedix's earnings, one of the primary drivers of an investment's value.

About Predictmedix Financial Statements

Predictmedix stakeholders use historical fundamental indicators, such as Predictmedix's revenue or net income, to determine how well the company is positioned to perform in the future. Although Predictmedix investors may analyze each financial statement separately, they are all interrelated. For example, changes in Predictmedix's assets and liabilities are reflected in the revenues and expenses on Predictmedix's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Predictmedix. Please read more on our technical analysis and fundamental analysis pages.
Predictmedix Inc., an artificial intelligence company, develops AI powered technologies for general workplace health and safety, and health care industry. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix is traded on OTC Exchange in the United States.

Currently Active Assets on Macroaxis

Other Information on Investing in Predictmedix Pink Sheet

Predictmedix financial ratios help investors to determine whether Predictmedix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Predictmedix with respect to the benefits of owning Predictmedix security.